Vanderbilt Therapeutics (VT) CRS — Nashville, Tennessee

Vanderbilt Therapeutics (VT) CRS is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt Therapeutics (VT) CRS has participated in 23 clinical trials with 3 currently active.

Therapeutic areas: HIV Infections, Treatment Naive, Sexually Transmitted Diseases.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Therapeutics (VT) CRS?

Vanderbilt Therapeutics (VT) CRS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Therapeutics (VT) CRS conducted?

Vanderbilt Therapeutics (VT) CRS has 23 clinical trials on record, with 3 currently active. Their work covers HIV Infections, Treatment Naive, Sexually Transmitted Diseases.

Is Vanderbilt Therapeutics (VT) CRS accredited by Crixeo Health?

Yes — Vanderbilt Therapeutics (VT) CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vanderbilt Therapeutics (VT) CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.